Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-In Capital	Accumulated OCI	Accumulated Deficit
Balance at Dec. 31, 2020	$ 75,868		$ 120,220	$ 284	$ (44,636)
Balance, Shares at Dec. 31, 2020		361,135,160
Issuance of Common Shares for vested director compensation	133		133
Issuance of Common Shares for vested director compensation, Shares		1,244,870
Vesting of restricted stock units		1,741,605
Issuance of Common Shares and warrants net of share issuance costs	81,928		81,928
Issuance of Common Shares and warrants net of share issuance costs, Shares		26,930,000
HealthMode acquisition	27,159		27,159
HealthMode acquisition, Shares		8,149,700
Exercise of warrants	10,676		10,676
Exercise of warrants, Shares		7,284,170
Exercise of stock options	5,273		5,273
Exercise of stock options, Shares		10,828,064
Stock-based compensation expense	28,844		28,844
Net loss and Comprehensive loss	(58,248)			763	(59,011)
Balance at Jun. 30, 2021	171,633		274,233	1,047	(103,647)
Balance, Shares at Jun. 30, 2021		417,313,569
Balance at Mar. 31, 2021	180,594		238,646	343	(58,395)
Balance, Shares at Mar. 31, 2021		405,586,054
Issuance of Common Shares for vested director compensation	68		68
Issuance of Common Shares for vested director compensation, Shares		622,435
Vesting of restricted stock units		1,741,605
Issuance of Common Shares and warrants net of share issuance costs	(186)		(186)
Exercise of warrants	3,978		3,978
Exercise of warrants, Shares		3,055,290
Exercise of stock options	4,096		4,096
Exercise of stock options, Shares		6,308,185
Stock-based compensation expense	27,631		27,631
Net loss and Comprehensive loss	(44,548)			704	(45,252)
Balance at Jun. 30, 2021	171,633		274,233	1,047	(103,647)
Balance, Shares at Jun. 30, 2021		417,313,569
Balance at Dec. 31, 2021	151,664		288,290	1,046	(137,672)
Balance, Shares at Dec. 31, 2021		421,896,217
Exercise of warrants	708		708
Exercise of warrants, Shares		1,140,313
Exercise of stock options	$ 164		164
Exercise of stock options, Shares	442,708	442,708
Settlement of restricted share unit awards		3,209,987
Withholding taxes paid on vested restricted share units	$ (407)		(407)
Stock-based compensation expense	7,979		7,979
Net loss and Comprehensive loss	(35,604)			(196)	(35,408)
Balance at Jun. 30, 2022	124,504		296,734	850	(173,080)
Balance, Shares at Jun. 30, 2022		426,689,225
Balance at Mar. 31, 2022	136,805		291,931	997	(156,123)
Balance, Shares at Mar. 31, 2022		422,401,776
Exercise of warrants	590		590
Exercise of warrants, Shares		952,462
Exercise of stock options	41		41
Exercise of stock options, Shares		125,000
Settlement of restricted share unit awards		3,209,987
Stock-based compensation expense	4,172		4,172
Net loss and Comprehensive loss	(17,104)			(147)	(16,957)
Balance at Jun. 30, 2022	$ 124,504		$ 296,734	$ 850	$ (173,080)
Balance, Shares at Jun. 30, 2022		426,689,225